Skip to main content

Table 1 Demographics/tumour characteristics

From: Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience

  ES-SBA LS-SBA
N (%) = 48 N (%) = 59
Gender   
 Male 28 (58.3) 31 (52.5)
 Female 20 (41.7) 28 (47.5)
Age (mean & range) 57 (28–78) 59 (28 – 87)
Median 59 61
Site of Primary tumour   
 Duodenum 30 (62.5) 40 (67.8)
 Jejunum 10 (20.8) 11 (18.6)
 Ileum 7 (14.6) 8 (13.6)
 Small bowel unknown 1 (2.1) 0 (0)
Grade (differentiation)   
 Low and moderate 27 (56.3) N/A
 Poor 20 (41.7)  
 Missing 1 (2.1)  
Nodes harvested   
 ≤12 21 (43.8) N/A
 >12 16 (33.3)  
 Missing 11 (22.9)  
Nodes involved (in those harvested)   N/A
 Negative (stage I/II) 30 (62.5)  
 Positive (Stage III) 12 (25.0)  
 Missing 6 (12.5)  
LVI   
 No 18 (37.5) N/A
 Yes 22 (45.8)  
 Missing 8 (16.7)  
PNI   
 No 29 (60.4) N/A
 Yes 11 (22.9)  
 Missing 8 (16.7)  
Resection Status   
 R0 44 (91.6) N/A
 R1 4 (8.4)  
Adjuvant Chemo   
 No 21 (44.9) N/A
 Yes 27 (55.1)  
 Single 9 (18.8)  
 Multiple 18 (37.5)  
Disease status   
 Locally Advanced N/A 5 (8.5)
 Metastatic   54 (91.5)
First Line Chemo   
 No N/A 13 (22.0)
 Yes   46 (78.0)